Crovalimab,Eculizumab
AstraZeneca,Roche,Chugai Pharmaceutical
['obinu', 'genentech']
#breaking: we presented positive results from a phase iii study comparing our novel anti-c5 recycling antibody against a standard of care in paroxysmal nocturnal hemoglobinuria, a rare and life-threatening blood condition. learn more: #eha2023 
Official Twitter for Genentech. See our community guidelines here: https://t.co/yas51FPhKU